UnitedHealth Group (UNH)

VIRGINIA BEACH, Va. - April 28, 2025 - PRLog -- Schonfeld & Associates, a publisher of business information products for over 40 years, has released the 2025 edition of SG&A Benchmarks for the Finance, Insurance, Real Estate industry sector. The report is a convenient source of information for professional managers seeking benchmark information on Selling, General & Administrative spending by major public corporations within the sector. Metrics for public companies provide important insight for other firms within the sector. SG&A expenses are all the direct and indirect selling expenses and all general and administrative expenses. SG&A expenses are also called Operating Expenses. Frequently, SG&A to Sales ratios are used to judge efficiency of management spending.Benchmarks for SG&A spending are hard to find. Averages may be available but are generally too broad to be useful. Within SG&A Benchmarks, the sector summary charts provide side by side comparison of annual median values for each industry within the sector for 2021-2024 as well as a chart of 10%ile, median and 90%ile values of SG&A to Sales ratio for 2024 by industry to illustrate the range of values reported by firms within each industry. To account for SG&A spending practices varying by size of revenues, individual companies are grouped based on fiscal 2024 sales. The detailed tables for each of the individual industries are presented with the companies in three groups as defined by sales of less than $100 million, sales between $100 million and $1 billion, and sales of more than $1 billion. The information presented for each company includes: fiscal 2023 and fiscal 2024 SG&A as a percentage of sales, annual percentage growth rate in SG&A spending and in sales, total sales for fiscal 2024 and headquarters location. Comparing the growth rate of SG&A expenses and sales gives a snapshot of where the profitability of the firm may be heading.The Finance, Insurance and Real Estate sector reports SG&A spending information for over 1065 publicly traded companies in seven industries: Depository Institutions (including Bank of America, JPMorgan Chase, Citigroup, Wells Fargo), Non-depository Credit Institutions (including Fannie Mae, American Express, Discover Financial Services), Security & Commodity Brokers and Services (including Charles Schwab, Goldman Sachs, Morgan Stanley), Insurance Carriers (including Cigna Group, Berkshire Hathaway, UnitedHealth Group), Insurance Agents and Services (including Marsh & McLennan, Equitable Holdings, Aon), Real Estate (including eXp World Holdings, Cushman & Wakefield, Redfin, CBRE Group) and Holding and Other Investment Offices (including Equinix, Blackstone REIT, Prologis, Crown Castle).This report will benefit anyone seeking competitive benchmark intelligence including corporate staff, financial analysts, investment professionals, lenders, M&A advisors, appraisers and industry consultants.Visit https://saibooks.com/product/sga-benchmarks-finance/ for more information and to place a secure order for immediate download.

Ademi & Fruchter LLP is investigating possible securities fraud claims against UnitedHealth (NYSE: UNH). The investigation results from inaccurate statements UnitedHealth made regarding its business operations and prospects.

UnitedHealth Group, the largest health insurance firm in the U.S., has reduced its revenue forecast for 2025 after its customers on Medicare Advantage made use of their policies a lot more than the company had anticipated. The first quarter of the year registered a lower financial performance than the company had expected.

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of UnitedHealth Group Incorporated (NYSE: UNH) resulting from allegations that UnitedHealth may have issued materially misleading business information to the investing public.

UnitedHealth Group (NYSE: UNH) reported first quarter 2025 results and revised its outlook for the year.

NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of UnitedHealth Group Incorporated (NYSE: UNH) in connection with a report of an investigation by the United States Department of Justice into UnitedHealth’s billing practices.

NEW YORK, March 28, 2025 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of UnitedHealth Group Incorporated (NYSE: UNH) in connection with a report of an investigation by the United States Department of Justice into UnitedHealth’s billing practices.

UnitedHealth Group (NYSE: UNH) will release its first quarter 2025 financial results on Thursday, April 17, 2025, before the market opens, and will host a teleconference at 8:45 a.m. ET to discuss the results with analysts and investors. This call will be webcast on the Investor Relations page of the company’s website (www.unitedhealthgroup.com). The replay will be available through May 1 on the website.

NEW YORK, March 20, 2025 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of UnitedHealth Group Incorporated (NYSE: UNH) in connection with a report of an investigation by the United States Department of Justice into UnitedHealth’s billing practices.

Rising prices set by pharmaceutical companies are causing pharmacies across the United States to pay more for many drugs, impacting their ability to maintain high-quality care for patients.

Optum Rx is committed to making prescription drugs more affordable and the pharmacy experience simpler for consumers with chronic conditions, eliminating up to 25% of reauthorizations, which is equal to more than 10% of overall pharmacy prior authorizations.

NEW YORK, March 17, 2025 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of UnitedHealth Group Incorporated (NYSE: UNH) in connection with a report of an investigation by the United States Department of Justice into UnitedHealth’s billing practices.

AM Best has affirmed the Long-Term Issuer Credit Ratings (Long-Term ICR) of “a” (Excellent) and the Long- and Short-Term Issuer Credit Ratings (Long-Term IR; Short-Term IR) of UnitedHealth Group Incorporated (UnitedHealth Group) (Minnetonka, MN) [NYSE: UNH]. Concurrently, AM Best has affirmed the Financial Strength Rating (FSR) of A+ (Superior) and the Long-Term ICRs of “aa-” (Superior) of the health and dental insurance subsidiaries of UnitedHealth Group, collectively referred to as UnitedHealthcare. The outlook of these Credit Ratings (ratings) is stable. (See link below for a detailed listing of the companies and ratings.)

NEW YORK, March 09, 2025 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces it is investigating potential breaches of fiduciary duties by the directors and officers of UnitedHealth Group Incorporated (NYSE: UNH) in connection with a report of an investigation by the United States Department of Justice into UnitedHealth’s billing practices.

NEW YORK, March 05, 2025 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces it is investigating potential breaches of fiduciary duties by the directors and officers of UnitedHealth Group Incorporated (NYSE: UNH) in connection with a report of an investigation by the United States Department of Justice into UnitedHealth’s billing practices.

NEW YORK, March 02, 2025 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces it is investigating potential breaches of fiduciary duties by the directors and officers of UnitedHealth Group Incorporated (NYSE: UNH) in connection with a report of an investigation by the United States Department of Justice into UnitedHealth’s billing practices.

NEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) --

The UnitedHealth Group (NYSE: UNH) board of directors has authorized payment of a cash dividend of $2.10 per share, to be paid on March 18, 2025, to all shareholders of record of UNH common stock as of the close of business March 10, 2025.

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential breaches of fiduciary duties by the directors and officers of UnitedHealth Group Incorporated (NYSE: UNH) in connection with a report of an investigation by the United States Department of Justice into UnitedHealth’s billing practices.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of UnitedHealth Group Incorporated (“UnitedHealth” or “the Company”) (NYSE: UNH) for violations of the securities laws.

The Wall Street Journal continues to report misinformation on the Medicare Advantage (MA) program. The government regularly reviews all MA plans to ensure compliance and we consistently perform at the industry’s highest levels on those reviews. We are not aware of the “launch” of any “new” activity as reported by the Journal. We are aware, however, that the Journal has engaged in a year-long campaign to defend a legacy system that rewards volume over keeping patients healthy and addressing their underlying conditions. Any suggestion that our practices are fraudulent is outrageous and false.

UnitedHealth Group (NYSE: UNH) reported full year and fourth quarter 2024 results reflecting diversified growth in serving people more extensively at Optum and UnitedHealthcare.

UnitedHealth Group (NYSE: UNH) will release its fourth quarter and full year 2024 financial results on Thursday, January 16, 2025, before the market opens, and will host a teleconference at 8:45 a.m. ET to discuss the results with analysts and investors. This call will be webcast on the Investor Relations page of the company’s website (www.unitedhealthgroup.com). The replay will be available through January 30 on the website.

UnitedHealth Group today issued the following update:

UnitedHealth Group today issued the following statement: